The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by 89 Zr-immuno-PET in xenograft bearing mice
Chomet, Marion, Schreurs, Maxime, Nguyen, Margaret, Howng, Bruce, Villanueva, Ruth, Krimm, Michael, Vasiljeva, Olga, van Dongen, Guus A.M.S, Vugts, Danielle J.Volume:
10
Year:
2020
Journal:
Theranostics
DOI:
10.7150/thno.44334
File:
PDF, 1.92 MB
2020